Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Propranolol

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    74 result(s) found for: Propranolol. Displaying page 1 of 4.
    1  2  3  4  Next»
    EudraCT Number: 2019-002947-41 Sponsor Protocol Number: N19PCA Start Date*: 2019-11-20
    Sponsor Name:Netherlands Cancer Institute- Antoni van Leeuwenhoek
    Full Title: Neoadjuvant trial on the efficacy of propranolol monotherapy in angiosarcoma (PROPANGIO).
    Medical condition: Angiosarcoma
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-004798-29 Sponsor Protocol Number: not-applicable Start Date*: 2014-04-22
    Sponsor Name:
    Full Title: The effects of propranolol on fear of tooth or molar removal: A randomized, placebo-controlled, double-blind, parallel design trial
    Medical condition: Excessive fear of tooth or molar removal.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-002062-39 Sponsor Protocol Number: AOUMeyer#1 Start Date*: 2013-11-04
    Sponsor Name:Azienda Ospedaliero-Universitaria Meyer
    Full Title: Safety and efficacy of propranolol eye drops in neonates with retinopathy of prematurity: a pilot study (DROP-ROP).
    Medical condition: The medical condition to be investigated is Retinopathy of Prematurity (ROP)
    Disease:
    Population Age: Preterm newborn infants, Under 18 Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2016-002392-10 Sponsor Protocol Number: S59302 Start Date*: 2017-02-02
    Sponsor Name:UZ Leuven
    Full Title: Reconsolidation interference versus retrieval interference as the basis for experimental amnesia in humans – The effect of drug state at memory retrieval
    Medical condition: Experimental study with healthy participants recruited from the general population; no vulnerable individuals or clinical groups will be involved. Our objective is to test wether the internal drug ...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2018-003409-25 Sponsor Protocol Number: S61887 Start Date*: 2018-11-08
    Sponsor Name:KU Leuven
    Full Title: Dose-dependent effects of propranolol on extinction learning and return of fear
    Medical condition: Experimental study with healthy participants recruited from the general population; no vulnerable individuals or clinical groups will be involved. Our objective is to test whether propranolol admin...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2009-014572-22 Sponsor Protocol Number: CDP0902 Start Date*: 2010-07-22
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: The use of topical propranolol in pyogenic granulomas
    Medical condition: pyogenic granulomas
    Disease: Version SOC Term Classification Code Term Level
    9.1 10029539 LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2022-001184-28 Sponsor Protocol Number: PeP-RALP Start Date*: 2022-10-11
    Sponsor Name:Oslo University Hospital
    Full Title: Perioperative Propranolol in Robotic Assisted Laparoscopic Prostatectomy - A Pilot Study A parallel-group, phase 2, double-blind, 2-arm study to assess the feasibility of conducting a formal large...
    Medical condition: Prostate Cancer
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: NO (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-005177-21 Sponsor Protocol Number: 2015-29 Start Date*: 2016-01-28
    Sponsor Name:Assistance Publique Hôpitaux de MARSEILLE
    Full Title: Dose-Finding of Propranolol in combination with metronomic fixed oral cyclophosphamide based on Bivariate efficacy-tolerability outcome in patients with locally advanced or metastatic angiosarcoma ...
    Medical condition: Patients presenting angiosarcomas disease
    Disease:
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-001380-13 Sponsor Protocol Number: PROPADB-01 Start Date*: 2014-08-08
    Sponsor Name:Abelardo Garcia De Lorenzo / Teresa Nuñez-Villaveiran
    Full Title: Effects of the treatment with propranolol in the burnt adult intubated patient with sinusal tachycardia induced by burns.
    Medical condition: BURNT-INDUCED SINUSAL TACHYCARDIA
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-003671-30 Sponsor Protocol Number: VHL-HOPE-2014-1 Start Date*: 2014-10-31
    Sponsor Name:ALIANZA ESPAÑOLA DE FAMILIAS DE VON HIPPEL-LINDAU
    Full Title: Therapeutic effect of propranolol in a series of patients with von Hippel-Lindau disease and retinal hemangioblastomas in short, medium and long term treatment.
    Medical condition: VON HIPPEL-LINDAU DISEASE
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2022-001174-54 Sponsor Protocol Number: APHP210075 Start Date*: 2022-05-19
    Sponsor Name:Assistance Publique – Hôpitaux de Paris (AP-HP)
    Full Title: Efficacy of Propranolol for the treatment of central nervous system hemangioblastomas in von Hippel-Lindau disease: a randomized controlled clinical trial ...
    Medical condition: von Hippel-Lindau desease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2009-014571-49 Sponsor Protocol Number: CDP0901 Start Date*: 2010-01-15
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: The use of systemic propranolol in congenital hemangiomas
    Medical condition: congenital hemangiomas
    Disease: Version SOC Term Classification Code Term Level
    12.1 10018818 Haemangioma congenital LLT
    Population Age: Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-004629-18 Sponsor Protocol Number: helmich-veni-2019 Start Date*: 2017-04-13
    Sponsor Name:Radboud University Nijmegen
    Full Title: The noradrenergic basis of Parkinson’s tremor: a systems-level fMRI approach
    Medical condition: Tremor in Parkinson's disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2009-017241-55 Sponsor Protocol Number: RC 43/08 Start Date*: 2009-12-09
    Sponsor Name:ISTITUTO PER L`INFANZIA BURLO GAROFOLO
    Full Title: Open randomized study on propranolol vs prednisone for haemangioma in patients younger than 18 months of age
    Medical condition: Haemagiomas
    Disease: Version SOC Term Classification Code Term Level
    12.1 10018823 Haemangioma of skin LLT
    Population Age: Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2010-018737-21 Sponsor Protocol Number: Studio PROP-ROP Start Date*: 2010-02-25
    Sponsor Name:AZIENDA OSPEDALIERA MEYER
    Full Title: Safety and efficacy of treatment with propranolol in newborns suffering from rethinopathy of the preterm: a pilot study
    Medical condition: Retinopathy of the preterm
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047060 HLGT
    Population Age: Preterm newborn infants, Under 18 Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-018102-22 Sponsor Protocol Number: V00400SB102 Start Date*: 2010-03-26
    Sponsor Name:PIERRE FABRE DERMATOLOGIE
    Full Title: A multicentre, open-label, repeated-dose, pharmacokinetic study of Propranolol in infants treated for proliferating infantile hemangiomas (IHs) requiring systemic therapy.
    Medical condition: Proliferating Infantile Hemangioma
    Disease: Version SOC Term Classification Code Term Level
    12.1 10018814 Haemangioma LLT
    Population Age: Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2017-002124-24 Sponsor Protocol Number: ROPROP Start Date*: 2017-12-22
    Sponsor Name:Universität Zürich
    Full Title: Oral Propranolol for prevention of threshold retinopathy of prematurity
    Medical condition: Retinopathy of prematurity
    Disease:
    Population Age: Preterm newborn infants, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: DE (Trial now transitioned)
    Trial results: View results
    EudraCT Number: 2009-014532-37 Sponsor Protocol Number: JU-AMG-403-1-1 Start Date*: 2011-01-13
    Sponsor Name:Universitätsklinikum Schleswig-Holstein
    Full Title: Effekte von oraler Cortisol oder Propranolol-Gabe auf die Verarbeitung alkoholbezogener Schlüsselreize, den Schlaf und das Rückfallrisiko von alkoholabhängigen Patienten (Copro-Studie).
    Medical condition: alkohol dependence
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-003595-30 Sponsor Protocol Number: IRFMN-7358 Start Date*: 2018-02-21
    Sponsor Name:IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
    Full Title: Treat_CCM Clinical Trial. A multicenter randomized clinical trial on Propranolol in Cerebral Cavernous Malformation
    Medical condition: Cerebral Cavernous Malformation (CCM)
    Disease: Version SOC Term Classification Code Term Level
    23.0 10010331 - Congenital, familial and genetic disorders 10071747 Cerebral cavernous malformation PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2020-000934-16 Sponsor Protocol Number: Nl.060.44183 Start Date*: 2020-06-18
    Sponsor Name:TNO
    Full Title: Reconsolidation: a new intervention towards combat-related PTSD.
    Medical condition: Post-traumatic stress disorder.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 14 11:42:01 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA